Identification And Evaluation Of Biomarkers For Huntingtons Disease PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Identification And Evaluation Of Biomarkers For Huntingtons Disease PDF full book. Access full book title Identification And Evaluation Of Biomarkers For Huntingtons Disease.

Identification and Evaluation of Biomarkers for Huntington's Disease

Identification and Evaluation of Biomarkers for Huntington's Disease
Author: E. J. Wild
Publisher:
Total Pages:
Release: 2009
Genre:
ISBN:

Download Identification and Evaluation of Biomarkers for Huntington's Disease Book in PDF, ePub and Kindle

Huntington's disease (HD) is a devastating, incurable inherited neurodegenerative disorder that commonly affects adults in mid-life. Despite encouraging results from in vitro and animal trials, disease-modifying therapeutic trials in HD are limited by a lack of tools to track disease progression. HD is clinically heterogeneous, and current clinical rating scales lack sensitivity and specificity, particularly over relatively short time periods. Improvements in the precision of objective measurement of disease progression in HD could lead to state markers (biomarkers) better able to predict onset, detect progression and measure the effects of therapeutic intervention. Biomarkers capable of detecting disease-related changes in premanifest gene carriers will be essential for clinical trials of treatments to delay onset. Imaging, clinical and cognitive assessment as well as laboratory markers have all been proposed as biomarkers, but few measures have been quantified over short time intervals or shown to be predictive of clinical change over longer periods. A robust panel of biomarkers from a number of modalities will be necessary to progress to interventional clinical trials of disease-modifying therapies in HD, using biomarkers to measure the success or failure of an intervention. Such cross-validation requires simultaneous multimodal biomarker evaluation within a suitable cohort of subjects studied longitudinally. This thesis describes a multi-modal approach to the discovery and evaluation of potential biomarkers for Huntington's disease in a large cohort of human volunteers. After reviewing the relevant features of Huntington's disease and current state of biomarker research in Huntington's disease, several approaches to, and outcomes from, biomarker discovery and evaluation are described, including proteomic profiling, targeted ELISA, multiplex inflammatory profiling and measurement of whole-brain atrophy by longitudinal magnetic resonance imaging. The thesis draws together these different approaches and summarises the contributions to both biomarker research and our understanding of the neurobiology of HD that the work has generated.


Pursuit of Cognitive Biomarkers

Pursuit of Cognitive Biomarkers
Author: P. Sasha Bruneau-Herman
Publisher:
Total Pages: 424
Release: 2013
Genre: Biochemical markers
ISBN:

Download Pursuit of Cognitive Biomarkers Book in PDF, ePub and Kindle

Recent research findings have challenged the conventional view of Huntington's Disease (HD) as a disease primarily of the basal ganglia and striatal-frontal circuits. Use of cortical thickness mapping (an automated MRI technique) has revealed significant cortical thinning in the posterior cortex even in pre-symptomatic HD (Rosas et al., 2005). Three years ago Davison (2009) found posterior cortical thinning in a pre-symptomatic HD (PreHD) sample, accompanied by poorer performance on some cognitive tasks thought to depend upon posterior brain regions, with unimpaired performance on anterior tasks, suggesting there may be functional effects of cortical changes identified by neuroimaging. The research in this thesis involves a follow-up study to Davison, involving the same PreHD (n=18) and matched Control participants (n=17). The same neuropsychological measures used in the first assessment were administered to examine cognitive and mood changes over the three years. Based on the logic that the cortical thinning identified at the first assessment was due to the HD gene, and the poorer performance on tasks selected to recruit these brain regions was a consequence of that thinning, it was predicted that poorer performance would be evident in the PreHD group on the same cognitive tasks at the second time-point. Given the PreHD participants have progressed towards clinical onset, it was also hypothesised that performance on posterior tasks would have declined, particularly in individuals closest to clinical onset. Lastly, we predicted the PreHD group would be unimpaired on tasks sensitive to anterior brain regions Consistent with these predictions, the pre-symptomatic group performed more poorly than Controls on three tasks sensitive to posterior brain regions (Judgement of Line Orientation Test, Roadmap test and Benton Facial Recognition). Decline was evident on two tasks (Roadmap test and Benton Facial Recognition), most pronounced for those close to clinical onset, while PreHD performance was unremarkable on anterior tasks. These findings suggest there are functional consequences of posterior cortical thinning found in pre-symptomatic HD. The findings also reveal potential candidates for cognitive biomarkers that may be sensitive to detecting, and tracking, progression of functional changes resulting from cortical changes occurring very early in the disease.


Biomarkers in Alzheimer's Disease

Biomarkers in Alzheimer's Disease
Author: Tapan Khan
Publisher: Academic Press
Total Pages: 278
Release: 2016-08-02
Genre: Psychology
ISBN: 0128051477

Download Biomarkers in Alzheimer's Disease Book in PDF, ePub and Kindle

Biomarkers in Alzheimer’s Disease provides a comprehensive overview of all modalities of Alzheimer’s disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer’s disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer’s disease, and for differential diagnosis of Alzheimer’s disease with other non-Alzheimer’s dementia. Presents a comprehensive overview detailing all modalities of Alzheimer’s disease biomarkers Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer’s Disease Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer’s disease and the technological advancement of biomarkers techniques


Neurodegenerative Diseases Biomarkers

Neurodegenerative Diseases Biomarkers
Author: Philip V. Peplow
Publisher:
Total Pages: 565
Release: 2021
Genre: Biochemical markers
ISBN: 9781071617120

Download Neurodegenerative Diseases Biomarkers Book in PDF, ePub and Kindle

This volume presents recent data on the latest achievements in new and emerging technologies for biomarkers and for innovations in their assessment. The chapters cover topics such as activation of microglia and macrophages in neurodegenerative diseases; oxidative stress and cellular dysfunction in neurodegenerative diseases; TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders; and imaging biomarkers in Huntington's disease and amyotrophic lateral sclerosis. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and comprehensive, Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice is a valuable resource for both experimental and clinical experts in the field of neurodegenerative diseases who are looking to expand their knowledge of novel biomarkers in different types of neurodegenerative diseases.


The Neuropathology of Huntington’s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy

The Neuropathology of Huntington’s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy
Author: Udo Rüb
Publisher: Springer
Total Pages: 154
Release: 2015-09-29
Genre: Medical
ISBN: 331919285X

Download The Neuropathology of Huntington’s Disease: Classical Findings, Recent Developments and Correlation to Functional Neuroanatomy Book in PDF, ePub and Kindle

This monograph describes the progress in neuropathological HD research made during the last century, the neuropathological hallmarks of HD and their pathogenic relevance. Starting with the initial descriptions of the progressive degeneration of the striatum as one of the key events in HD, the worldwide practiced Vonsattel HD grading system of striatal neurodegeneration will be outlined. Correlating neuropathological data with results on the functional neuroanatomy of the human brain, subsequent chapters will highlight recent HD findings: the neuronal loss in the cerebral neo-and allocortex, the neurodegeneration of select thalamic nuclei, the affection of the cerebellar cortex and nuclei, the involvement of select brainstem nuclei, as well as the pathophysiological relevance of these pathologies for the clinical picture of HD. Finally, the potential pathophysiological role of neuronal huntingtin aggregations and the most important and enduring challenges of neuropathological HD research are discussed.


Hyperkinetic Movement Disorders

Hyperkinetic Movement Disorders
Author: Alberto Albanese
Publisher: John Wiley & Sons
Total Pages: 413
Release: 2012-03-07
Genre: Medical
ISBN: 1444346164

Download Hyperkinetic Movement Disorders Book in PDF, ePub and Kindle

Hyperkinetic movement disorders comprise a range of diseases characterized by unwanted and uncontrollable, or poorly controllable, involuntary movements. The phenomenology of these disorders is quite variable encompassing chorea, tremor, dystonia, myoclonus, tics, other dyskinesias, jerks and shakes. Discerning the underlying condition can be very difficult given the range and variability of symptoms. But recognizing the phenomenology and understanding the pathophysiology are essential to ensure appropriate treatment. Hyperkinetic Movement Disorders provides a clinical pathway for effective diagnosis and management of these disorders. The stellar international cast of authors distils the evidence so you can apply it into your practice. The judicious use of diagnostic criteria algorithms rating scales management guidelines Provides a robust framework for clear patient management. Throughout the text, QR codes* provide smartphone access to case-study videos of hyperkinetic symptoms. Purchase includes an enhanced Wiley Desktop Edition.* This is an interactive digital version featuring: all text and images in fully searchable form integrated videos of presentations View a sample video: www.wiley.com/go/albanese highlighting and note taking facilities book marking linking to additional references Hyperkinetic Movement Disorders provides you with the essential visual and practical tools you need to effectively diagnose and treat your patients. *Full instructions for using QR codes and for downloading your digital Wiley DeskTop Edition are inside the book.


Epigenetic Biomarkers and Diagnostics

Epigenetic Biomarkers and Diagnostics
Author: Jose Luis Garcia-Gimenez
Publisher: Academic Press
Total Pages: 698
Release: 2015-12-07
Genre: Science
ISBN: 0128019212

Download Epigenetic Biomarkers and Diagnostics Book in PDF, ePub and Kindle

Epigenetic Biomarkers and Diagnostics comprises 31 chapters contributed by leading active researchers in basic and clinical epigenetics. The book begins with the basis of epigenetic mechanisms and descriptions of epigenetic biomarkers that can be used in clinical diagnostics and prognostics. It goes on to discuss classical methods and next generation sequencing-based technologies to discover and analyze epigenetic biomarkers. The book concludes with an account of DNA methylation, post-translational modifications and noncoding RNAs as the most promising biomarkers for cancer (i.e. breast, lung, colon, etc.), metabolic disorders (i.e. diabetes and obesity), autoimmune diseases, infertility, allergy, infectious diseases, and neurological disorders. The book describes the challenging aspects of research in epigenetics, and current findings regarding new epigenetic elements and modifiers, providing guidance for researchers interested in the most advanced technologies and tested biomarkers to be used in the clinical diagnosis or prognosis of disease. Focuses on recent progress in several areas of epigenetics, general concepts regarding epigenetics, and the future prospects of this discipline in clinical diagnostics and prognostics Describes the importance of the quality of samples and clinical associated data, and also the ethical issues for epigenetic diagnostics Discusses the advances in epigenomics technologies, including next-generation sequencing based tools and applications Expounds on the utility of epigenetic biomarkers for diagnosis and prognosis of several diseases, highlighting the study of these biomarkers in cancer, cardiovascular and metabolic diseases, infertility, and infectious diseases Includes a special section that discusses the relevance of biobanks in the maintenance of high quality biosamples and clinical-associated data, and the relevance of the ethical aspects in epigenetic studies